Visual Function After Implantation of AcrySof® Toric Lens

Alcon

Status and phase

Terminated

Phase 4

Conditions

Cataract

Treatments

Device: AcrySof Toric Intraocular Lens

Study type

Interventional

Funder types

Industry

Identifiers

NCT01074606

MT-0902

Details and patient eligibility

About

The objective of this study is to evaluate the postoperative visual function of Taiwanese patients following bilateral or unilateral AcrySof Toric Intraocular Lens (IOL) implantation.

Enrollment

56 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Prospective subjects should be adults and may be of any race and gender, and diagnosed with cataracts.
Subject must require extraction of cataracts followed by implantation of a posterior chamber intraocular lens.
All subjects must have between 0.75 - 2.0 Diopter (D) of astigmatism preoperatively as measured by keratometry readings.
For any second eye surgery in bilateral AcrySof Toric patients, it should be performed at least one week following the first eye implant but no longer than one month after the first implant.

Exclusion criteria

Subjects with pre-existing conditions that could skew the results should be excluded from the Study.
AcrySof® Toric product inserts under "Precautions" for subject groups that should be excluded from this Study.